Shanghai Frontier collaborates with top industry university research institutions to create an open source innovation ecosystem. Font: Small, Medium, and Large Share:
2024-08-09
On August 8th, Shanghai Pharma, in collaboration with top universities and research institutions, jointly established the China Biomedical Innovation "National Team" and launched the "Shanghai Frontier" brand, declaring that "Shanghai Frontier, Bridging for Success". This declaration not only reflects Shanghai Frontier's commitment to building a "research and development center without walls", but also promotes communication and cooperation among experts, scholars, enterprises, and investors from different fields and backgrounds in "industry, academia, research, medicine, and capital" by breaking down traditional barriers; At the same time, it also established the determination of Shanghai Frontier to stimulate new creativity and solutions through cross-border integration, accelerate the transformation and industrialization of scientific research achievements, and promote the high-quality development of the biopharmaceutical industry. Shanghai Frontier is located in the core area of Zhangjiang Science City, a national level biopharmaceutical base. This place gathers abundant resources and aims to provide a vibrant open cooperation platform for Chinese and global biopharmaceutical innovators. In the future, the park will provide comprehensive ecosystem support for settled enterprises, and through cooperation with global innovative enterprises and teams, jointly promote innovation and development in the field of biomedicine, and improve human health levels. Cold Weiqing, Chairman of Shangshi Group, stated that Shangshi Group and Shanghai Pharmaceuticals will rely on the forefront of Shanghai through market-oriented operations, gather national key laboratories, academician studios, intellectual property professional service institutions, "technology brokers" teams, fund matrices and other resources, create a first-class technology incubation and industry service platform, continuously strengthen the empowerment of key elements, and smooth the channel for the landing of innovative achievements. Today's cutting-edge brand launch in Shanghai showcases our determination to build an open, shared, and collaborative innovation industry ecosystem. We look forward to working with partners from all walks of life to overcome challenges, create brilliance, and write a new chapter in technology and health Shanghai Frontier adheres to the concept of leading, gathering momentum, accompanying, integrating, and co creating, gathering resources from all parties, building a "national team" for biomedical innovation, and showcasing the forefront of China's innovation power. As a large state-owned pharmaceutical industry group that has been listed on the Fortune Global 500 list and the top 50 global pharmaceutical companies for several consecutive years, Shanghai Pharmaceutical has always adhered to serving the national strategy, fully leveraging the advantages of integrated development of "industry, commerce, research and investment", and striving to play a leading role and make contributions in accelerating the development of Shanghai's biopharmaceutical industry. The Shanghai Frontier Park, which is about to grandly open in September, has attracted many enterprises and institutions such as national key research institutes, Bayer from Germany, SDIC, Shanghai Biomedical Fund, and Xunyao Biotechnology to settle in. Shanghai Frontier focuses on exploring and cultivating unicorn enterprises that are pioneers in industry change, innovation tracks, and cutting-edge technologies. It focuses on cutting-edge biotechnology such as gene cell therapy, nucleic acid drugs, and conjugate drugs, and is committed to filling the clinical demand gap in major disease fields such as autoimmune diseases, oncology, neurological diseases, and rare diseases. It is fully committed to promoting the introduction, incubation, and commercialization process of innovative projects. At present, innovative enterprises can submit their entry applications online through the "Shanghai Frontier Mini Program", a mobile platform that integrates information publishing, entry application, and park services, achieving "one click entry". This platform is also the only official entrance for submitting entry applications on mobile devices. In addition, the park is equipped with a Smart Operations Platform (SMOP) dedicated to providing efficient and flexible digital management. Yang Qiuhua, chairman of Shanghai Pharmaceutical, said: "In the new wave of scientific and technological revolution and industrial transformation, Shanghai Frontier is determined to build a service park for the world-class biomedical innovation industry cluster to incubate scientific and technological innovation and transform achievements throughout its life cycle. Our goal is to establish a platform for basic scientific research and industrial transformation, and nurture a sustainable and dynamic ecosystem of life science innovation. Shanghai Frontier is not only a brand, but also a commitment, representing innovation, excellence and the pursuit of unlimited possibilities for the future, which will be integrated and created together without boundaries." (La Xinshe)
Edit：HAN ZHUOLING Responsible editor：CAICAI
Source：xinhuanet.com
Special statement: if the pictures and texts reproduced or quoted on this site infringe your legitimate rights and interests, please contact this site, and this site will correct and delete them in time. For copyright issues and website cooperation, please contact through outlook new era email：lwxsd@liaowanghn.com
Recommended Reading Change it 
Home
